NEWS & EVENTS
NIBIB-funded bioengineers have teamed with their colleagues at the Wyss Institute for Biologically Inspired Engineering at Harvard University to develop a novel approach for disease diagnosis. The collaboration produced a diagnostic device composed of a small slip of paper with an array of RNA-activated sensors capable of identifying pathogens such as antibiotic-resistant bacteria and strain-specific Ebola virus. Read more and watch videos about the project at the Wyss Institute website.
A new light-based imaging method developed by NIBIB grantee Lihong Wang, Ph.D. and his team at Washington University in St. Louis enables researchers to see blood flow, blood oxygenation, and oxygen metabolism inside a living mouse brain at faster rates than ever before. Read more at news.wustl.edu.
NIBIB grantee Robert Langer wins the Kyoto Prize for his role as one of the founders of the field of tissue engineering and his development of innovative and unique drug delivery technologies for the controlled release of medicines to directly target tumors and disease sites. The Kyoto Prize is Japan’s highest international award for honoring the people who have made significant contributions to the scientific, cultural, and spiritual betterment of mankind.
NIBIB-funded researchers have developed a new technique that uses light to reveal structures and molecules inside tissue samples without the use of chemical stains or dyes. The technique has the potential to reduce the time, cost, and effort needed to analyze tissues for clinical diagnoses and biomedical research and to provide a more objective method of analysis.
NIBIB-funded researchers and their international colleagues have developed a novel fluorescence microscopy technique that allows researchers to directly observe proteins being produced from their coding messenger RNAs (mRNAs). The study was performed in live human cells and fruit fly embryos. The researchers aim to use the technique to study how irregularities in protein synthesis may contribute to a number of disease processes. Read more at Einstein College of Medicine press.
The National Institutes of Health has selected 16 finalists for Phase 1 of its Follow that Cell Challenge. The goal of the challenge is to stimulate the development of new tools and methods that will enable researchers to predict the behavior and function of a single cell in complex tissue over time. This ability could help reveal valuable information such as how cells transition from a healthy to diseased state, or identify changes that influence a cell’s responsiveness to treatment.
Most military battlefield casualties die before ever reaching a surgical hospital. Of those soldiers who might potentially survive, most die from uncontrolled bleeding. That’s why University of Washington researchers have developed a new injectable polymer called PolySTAT that strengthens blood clots. Read more at the University of Washington.
A research team including NIBIB-funded scientists has developed an improved MRI technique with the potential to provide more precise and effective treatment for prostate cancer. The imaging technique improves upon standard MRI to obtain clearer images of the extent of the tumor and its exact location. A sharper image can provide more accurate biopsies, enable better treatment planning, and help surgeons pinpoint the tumor while sparing surrounding healthy tissue.
From solar data collected on Antarctic ice plains where the December sun doesn’t set, to the hunt for new species in underground caves in Iran that light never penetrates, to space exploration in the interstellar medium beyond our solar system, the scope of NJIT’s research is vast and expanding.